 |
JOURNAL TOOLS |
| eTOC |
| Per abbonarsi |
| Sottometti un articolo |
| Segnala alla tua biblioteca |
ARTICLE TOOLS |
| Publication history |
| Estratti |
| Permessi |
| Per citare questo articolo |
| Share |
I TUOI DATI
I TUOI ORDINI
CESTINO ACQUISTI
N. prodotti: 0
Totale ordine: € 0,00
COME ORDINARE
I TUOI ABBONAMENTI
I TUOI ARTICOLI
I TUOI EBOOK
COUPON
ACCESSIBILITÀ
LETTERS TO THE EDITOR
Minerva Urology and Nephrology 2021 June;73(3):404-6
DOI: 10.23736/S2724-6051.20.04197-1
Copyright © 2020 EDIZIONI MINERVA MEDICA
lingua: Inglese
Delay in surgery for cT1b-2 kidney cancer beyond 90 days is associated with poorer survival: implications for prioritization during the COVID-19 pandemic
Wei-Shen TAN 1, 2, 3, Maya MARCHESE 3, 4, Marco PACIOTTI 3, 4, David-Dan NGUYEN 3, 4, Eugene B. CONE 3, 4, Matthew MOSSANEN 3, 4, 5, John J. WEBSTER 2, Ravi BAROD 6, Axel BEX 1, 6, Adam S. KIBEL 3, 5, Steven L. CHANG 3, 5, Quoc-Dien TRINH 3, 4, 5 ✉
1 Division of Surgery and Interventional Science, University College London, London, UK; 2 Department of Urology, Northwick Park Hospital, London, UK; 3 Division of Urological Surgery, Brigham and Women’s Hospital, Boston, MA, USA; 4 Center for Surgery and Public Health, Brigham and Women’s Hospital, Boston, MA, USA; 5 Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; 6 The Specialist Center for Kidney Cancer, Royal Free Hospital, London, UK